by Eric Christianson | Sep 25, 2019 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
by Eric Christianson | Aug 18, 2019 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Glucagon can be a lifesaver, literally. Glucagon’s primary use is in the setting of severe hypoglycemia. Glucagon works by increasing cyclic AMP which causes glycogenolysis and gluconeogenesis. This ultimately leads to an increase in glucose in the blood and helps...
by Eric Christianson | Jul 10, 2019 | Educational Case Studies For Pharmacists, Endocrine Case Studies
This guest post on selecting a diabetes medication was contributed by pharmacist Jiamin Liau who is also a Certified Diabetes Educator in Australia. I’m appreciative for her contribution to help educate other healthcare professionals! If you’re a...
by Eric Christianson | Apr 3, 2019 | Educational Case Studies For Pharmacists
About 10 days ago, a 76-year-old male called you to tell you that his spiking blood sugars are higher than they have been in a long time. His blood sugars were in the 300-400 range. He used to never get much above 200. He reports that he has had no diet changes and is...
by Eric Christianson | Dec 26, 2018 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
